🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, multi-center, phase 1 study of BBI608 and BBI503 adm...
Status
Completed
Location
University of Chicago Medicine Comprehensive Cancer Center
Start Date
2015-04
Trial ID
NCT02432326
This is an open label, multi-center, phase 1 safety run-in and phase 2 stud...
Status
Completed
Location
Laura and Isaac Perlmutter Cancer Center
Start Date
2015-03
Trial ID
NCT02315534
Treatments Being Tested
This is a multicenter, open label, Phase 1 dose-escalation study of BBI608 ...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05
Trial ID
NCT02352558
Treatments Being Tested
This is a phase I, single-center, open-label, single-sequence, 3-period, PK...
Status
Completed
Location
Accel Research Sites
Start Date
2017-06-30
Trial ID
NCT03411122
Treatments Being Tested
The purpose of this study is to find out whether it is better to receive a ...
Status
Completed
Location
Mayo Clinic - Arizona
Start Date
2014-10
Trial ID
NCT02178956
Treatments Being Tested
This is an open-label, multicenter, phase 1/2 study of BBI608 in combinatio...
Status
Completed
Location
National Cancer Center Hospital East
Start Date
2015-02
Trial ID
NCT02347917
Treatments Being Tested
This is a randomized, open-label, multi-center, phase III study of Napabuca...
Status
Unknown
Location
First Affiliated Hospital of Bengbu Medical College
Start Date
2018-04-12
Trial ID
NCT03522649
Treatments Being Tested
This is an open-label, multicenter, phase 1 study of BBI608 in combination ...
Status
Completed
Location
4 Sites
Start Date
2015-02
Trial ID
NCT02358395
This is a Phase I, single-center, open-label, single-sequence, study evalua...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-05-18
Trial ID
NCT03525405
Treatments Being Tested
This is an open label, single arm phase 1 dose escalation study and phase 2...
Status
Completed
Location
USC - University of Southern California Norris Comprehensive Cancer Center
Start Date
2011-04
Trial ID
NCT01325441
Treatments Being Tested